Trial intelligence / Profile preview

Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion in Essential Hypertension

2006-001669-41Phase 3Active

Sponsor
Aristotle University of Thessaloniki
Start
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of atorvastatin in essential hypertension and hypercholesterolemia, sponsored by Aristotle University of Thessaloniki. Primary endpoints: Ambulatory blood pressure, Urinary albumin excretion and 2 more. Started Nov 2006; status: active.

02

Drugs

atorvastatin
03

Conditions

essential hypertensionhypercholesterolemia

Beyond the preview

Go deeper on 2006-001669-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001669-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call